• Bioheart (Sunrise, Florida) said that Doug Owens, director, clinical affairs, will assume responsibility for Bioheart's regulatory and clinical strategy for its investigational MyoCell therapy clinical trials. Owens has previously managed the MARVEL trial for the company. Bioheart makes intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases.

Randy Thurman has been named executive chairman of CardioNet (Conshohocken, Pennsylvania). He most recently was chairman/CEO of Viasys Healthcare. CardioNet is a wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias.

Larry Hambleton has been named VP of sales and marketing for Micronics (Redmond, Washington). Previously, Hambleton was director of product marketing at Cepheid. Micronics makes molecular diagnostics for point-of-care detection of infectious diseases.

• Mobile Imaging Development (Las Vegas) reported that its limited partnership, Mobile Diagnostic Centers has named Patrick McNamara as director of marketing and operations. McNamara's previous mobile imaging experience includes the formation of a mobile PET/CT route that was launched just after the introduction of the Deficit Reduction Act of 2007. Mobile Diagnostic Centers is a mobile medical imaging services provider.

Dennis Meister was named president/CEO of Prenatek (Dublin, California). Meister, who brings more than 25 years of experience in leading product and market development of medical devices serving Women's Health, also will serve on the company's board of directors. Prenatek makes products for the detection and management of fetal well-being.